Trade

with

Lannett Co Inc
(NYSE: LCI)
AdChoices
49.30
+4.58
+10.24%
After Hours :
49.30
0.00
0.00%

Open

48.00

Previous Close

44.72

Volume (Avg)

1.36M (645.11k)

Day's Range

47.09-49.97

52Wk Range

21.11-51.66

Market Cap.

1.76B

Dividend Rate ( Yield )

-

Beta

1.14

Shares Outstanding

35.68M

P/E Ratio (EPS)

30.40 (1.62)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 273.77M

    • Net Income

    • 57.10M

    • Market Cap.

    • 1.76B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 20.86

    • PEG (Price/Earnings Growth) Ratio

    • 0.28

    • Beta

    • 1.14

    • Forward P/E

    • 17.21

    • Price/Sales

    • 6.34

    • Price/Book Value

    • 5.97

    • Price/Cash flow

    • 38.46

      • EBITDA

      • 96.13M

      • Return on Capital %

      • 22.37

      • Return on Equity %

      • 27.00

      • Return on Assets %

      • 22.37

      • Book Value/Share

      • 8.25

      • Shares Outstanding

      • 35.68M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 48.75

        • Credit Rating

        • -

        • Analysts

        • 4

        • EPS Estimate

        • 2.74

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 100.70

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • 328.80

          • -26.33

          • Net Income

            Q/Q (last year)

          • 560.50

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 18.13

          • -5.42

          • Net Income

            5-Year Annual Average

          • 54.30

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 56.40

            • 64.72

            • Pre-Tax Margin

            • 32.88

            • 13.77

            • Net Profit Margin

            • 20.86

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 36.20

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 12.30

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • 7.80

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.00

              • 0.33

              • Current Ratio

              • 5.65

              • 1.52

              • Quick Ratio

              • 4.42

              • 0.87

              • Interest Coverage

              • 693.46

              • 6.77

              • Leverage Ratio

              • 1.16

              • 1.91

              • Book Value/Share

              • 8.25

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 30.40

                • 65.36

                • P/E Ratio 5-Year High

                • 31.84

                • 237.47

                • P/E Ratio 5-Year Low

                • 2.10

                • 19.71

                • Price/Sales Ratio

                • 6.34

                • 3.63

                • Price/Book Value

                • 5.97

                • 3.39

                • Price/Cash Flow Ratio

                • 38.46

                • 21.83

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 27.00

                    (10.20)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • 22.37

                    (7.80)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • 26.55

                    (9.90)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • 143.11k

                  • 27.79k

                  • Inventory Turnover

                  • 3.09

                  • 1.80

                  • Asset Turnover

                  • 1.07

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  88.09M
                  Operating Margin
                  32.18
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  38.46
                  Ownership

                  Institutional Ownership

                  48.76%

                  Top 10 Institutions

                  25.03%

                  Mutual Fund Ownership

                  30.98%

                  Float

                  82.23%

                  5% / Insider Ownership

                  20.20%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • PowerShares Dynamic Pharmaceuticals Port

                  •  

                    1,041,124

                  • 0.00

                  • 3.15

                  • SPDR® S&P Pharmaceuticals ETF

                  •  

                    808,641

                  • 0.00

                  • 2.22

                  • iShares Core S&P Small-Cap (AU)

                  •  

                    533,871

                  • 0.57

                  • 1.46

                  • Vanguard Small Cap Index

                  •  

                    401,634

                  • -0.35

                  • 1.13

                  • iShares Russell 2000 (AU)

                  •  

                    387,379

                  • -1.81

                  • 1.06

                  • Vanguard Total Stock Mkt Idx

                  •  

                    371,262

                  • 0.00

                  • 1.04

                  • Trans Small Cap Growth Fund

                  •  

                    301,820

                  • 89.76

                  • 0.85

                  • DFA US Small Cap Value II Portfolio

                  •  

                    278,478

                  • 0.00

                  • 0.78

                  • Vanguard Small Cap Growth Index Fund

                  •  

                    271,385

                  • -2.17

                  • 0.76

                  • Vanguard Extended Market Index Fund

                  •  

                    243,466

                  • -7.16

                  • 0.68

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Group, Inc.

                  •  

                    1,638,961

                  • +54.75%

                  • 4.61

                  • BlackRock Fund Advisors

                  •  

                    1,375,242

                  • +163.95%

                  • 3.87

                  • Dimensional Fund Advisors, Inc.

                  •  

                    1,228,713

                  • +2.96%

                  • 3.45

                  • State Street Corp

                  •  

                    1,070,045

                  • +16.12%

                  • 3.01

                  • Invesco PowerShares Capital Mgmt LLC

                  •  

                    1,021,504

                  • -0.71%

                  • 2.87

                  • Ranger Investment Management, L.P.

                  •  

                    1,017,458

                  • +83.40%

                  • 2.86

                  • Quantitative Management Associates LLC

                  •  

                    504,250

                  • +68.44%

                  • 1.42

                  • Century Capital Management, LLC

                  •  

                    382,429

                  • -45.66%

                  • 1.08

                  • First Investors Management Company, Inc

                  •  

                    322,300

                  • +54.58%

                  • 0.91

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Aggressive Growth

                  Style

                  Small Growth

                  Lannett Co Inc was incorporated in 1942 under the laws of the Commonwealth of Pennsylvania, and reincorporated in 1991 as a Delaware corporation. The Company develops, manufactures, markets and distributes generic versions of branded...more pharmaceutical products. The Company manufactures solid oral dosage forms, including tablets and capsules, extended release, topicals, oral solutions and distributes parenteral as well as ophthalmics. All of the products are currently manufactured and sold are prescription products. The Company's products containing Levo are produced and marketed with 12 varying potencies. In addition to generic Levo tablets, it also market and distribute Unithroid tablets, a branded version of Levo, which is produced and marketed with 11 varying potencies. Both generic Levo tablets and...more Unithroid tablets are manufactured by JSP. Lannett began buying generic Levo from JSP and selling it to its customers in April 2003. Levo tablets are used to treat hypothyroidism and other thyroid disorders. Levo remains the most prescribed drugs in the U.S. and is used by over 13 million patients of various ages and demographic backgrounds. In distribution of these products, the Company competes with two branded Levo products-Abbott Laboratories Synthroid(r) and Monarch Pharmaceuticals Levoxyl(r)- as well as generic products from Mylan and Sandoz. Digoxin tablets are produced and marketed with two different potencies, 0.125mg and 0.25mg per tablet. This product is manufactured by JSP. Lannett began buying this product from JSP and selling it to its customers in September 2002. Digoxin tablets are used to treat congestive heart failure in patients of various ages and demographic backgrounds. The Company distributes two products containing Butalbital. Lannett has manufactured and sold one of the products, Butalbital with Aspirin and Caffeine capsules, for more than nine years. The other Butalbital product, Butalbital with Aspirin, Caffeine and Codeine Phosphate capsules, is manufactured by JSP. Lannett began buying this product from JSP and selling it to its customers in December 2002. Both Butalbital products, which are in orally administered capsule dosage forms, are prescribed to treat tension headaches caused by contractions of the muscles in the neck and shoulder area and migraine. Primidone tablets are produced and marketed with two different potencies, 50mg and 250mg tablets. Lannett has developed and manufacture Primidone tablets and began selling Primidone 50mg tablets in June 2001. In addition, the Company has been manufacturing and selling Primidone 250mg tablets for more than seven years. Both Primidone products, which are in orally administered tablet dosage forms, are prescribed to treat convulsion and seizures in epileptic patients of all ages and demographic backgrounds. Lannett sell its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, governmental entities and health maintenance organizations. Lannett Company markets generic equivalents of the following brands: Diamox, Symmetrel, Lioresal, Urecholine, Fiorinal, Cleocin, Danocrine, Bentyl, Lanoxin, Persantine, Adoxa, Periostat, Estratest, Hydrodiuril, Dilaudid. The Company promotes its products through direct sales, trade shows, trade publications and bids. Lannett is subject to regulation by the federal government, mainly by the FDA and the Drug Enforcement Agency, and to a lesser extent, by other federal regulatory bodies and state governments.lessless

                  Key People

                  Mr. Arthur P. Bedrosian, J.D.

                  CEO/Director/President

                  Mr. Jeffrey M. Farber

                  Chairman of the Board/Director

                  Mr. Martin P. Galvan, C.P.A.

                  CFO/Treasurer/Vice President, Divisional

                  Mr. Robert Ehlinger

                  Chief Information Officer/Vice President, Divisional

                  Mr. Kevin R. Smith

                  Vice President, Divisional

                  • Lannett Co Inc

                  • 9000 State Road

                  • Philadelphia, PA 19136

                  • USA.Map

                  • Phone: +1 215 333-9000

                  • Fax: +1 215 333-9004

                  • lannett.com

                  Incorporated

                  1942

                  Employees

                  399

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: